Professional
Added to YB: 2025-06-27
Pitch date: 2025-04-12
BRKR [neutral]
Bruker Corporation
+56.56%
current return
Author Info
No bio for this author
Company Info
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions.
Market Cap
$8.3B
Pitch Price
$39.37
Price Target
N/A
Dividend
0.37%
EV/EBITDA
18.34
P/E
-226.89
EV/Sales
2.86
Sector
Life Sciences Tools and Services
Category
growth
BBH Select Series - Mid Cap Fund Portfolio Holding: Bruker Corporation
BRKR (holding update): Declined 28.7% due to slow 2025 outlook from delayed China stimulus, slow biopharma recovery, and government funding cuts affecting academic research clients. Well-diversified across Americas/EMEA/Asia-Pacific with industrial, biopharma, semi-metrology and diagnostics markets beyond academic/government customers.
Read full article (1 min)